Cholesterol-lowering response to atorvastatin is modified by CYP3A5'AST'3 allele in Brazilian hypercholesterolemic patients (2006)
- Authors:
- Hirata, Rosario Dominguez Crespo
- Willrich, Maria Alice Vieira
- Dorea, Egidio Lima
- Bernik, Márcia Martins Silveira
- Bertolami, Marcelo Chiara
- Faludi, André Arpad
- Rebecchi, Ivanise Marina Moretti
- Sorkin, Simone Cohen
- Dalla-Vecchia, Fabiana
- Rodrigues, Alice Cristina
- Basques, Helder Honorato
- Oliveira, Verônica Simões de
- Hirata, Mario Hiroyuki
- Hirata, Rosario Dominguez Crespo
- USP affiliated authors: HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF ; HIRATA, MARIO HIROYUKI - FCF ; DOREA, EGIDIO LIMA - HU ; BERNIK, MARCIA MARTINS SILVEIRA - HU ; REBECCHI, IVANISE MARINA MORETTI - HU
- Unidades: FCF; HU
- Subjects: HIPERCOLESTEROLEMIA; CITOCROMO P-450
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2006
- Source:
- Título: Clinical Chemistry
- ISSN: 0009-9147
- Volume/Número/Paginação/Ano: v. 52, n. 6, supl., p. A54-A55 res. B-52, 2006
- Conference titles: AACC Annual Meeting
-
ABNT
HIRATA, Rosario Dominguez Crespo et al. Cholesterol-lowering response to atorvastatin is modified by CYP3A5'AST'3 allele in Brazilian hypercholesterolemic patients. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 02 out. 2024. , 2006 -
APA
Hirata, R. D. C., Willrich, M. A. V., Dorea, E. L., Bernik, M. M. S., Bertolami, M. C., Faludi, A. A., et al. (2006). Cholesterol-lowering response to atorvastatin is modified by CYP3A5'AST'3 allele in Brazilian hypercholesterolemic patients. Clinical Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Hirata RDC, Willrich MAV, Dorea EL, Bernik MMS, Bertolami MC, Faludi AA, Rebecchi IMM, Sorkin SC, Dalla-Vecchia F, Rodrigues AC, Basques HH, Oliveira VS de, Hirata MH. Cholesterol-lowering response to atorvastatin is modified by CYP3A5'AST'3 allele in Brazilian hypercholesterolemic patients. Clinical Chemistry. 2006 ; 52( 6): A54-A55 res. B-52.[citado 2024 out. 02 ] -
Vancouver
Hirata RDC, Willrich MAV, Dorea EL, Bernik MMS, Bertolami MC, Faludi AA, Rebecchi IMM, Sorkin SC, Dalla-Vecchia F, Rodrigues AC, Basques HH, Oliveira VS de, Hirata MH. Cholesterol-lowering response to atorvastatin is modified by CYP3A5'AST'3 allele in Brazilian hypercholesterolemic patients. Clinical Chemistry. 2006 ; 52( 6): A54-A55 res. B-52.[citado 2024 out. 02 ] - Efeitos do polimorfismo G1051A do gene ABCA1 no perfil lipídico sérico de indivíduos hipercolesterolêmicos
- Associação do polimorfismo R219K do gene ABCA1 com perfil lipídico sérico menos aterogênico
- Effects of ABCA1 SNPs, including the C-105T novel variant, on serum lipids of Brazilian individuals
- Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response
- CYP3A5 polymorphism is associated with differences on gene expression and cholesterol-lowering response to atorvastatin
- Atorvastatin down-regulates ABCA1 gene expression in peripheral blood mononuclear cells of Brazilian hyper-cholesterolemic patients
- Atorvastatin effects on SREBF1 and SCAP gene expression in peripheral blood mononuclear cells of hypercholesterolemic patients
- Study of the variant of the leptin receptor (Lys109arg) and possible association with obesity and the development of diabetes
- Polimorfismos no receptor scavenger classe B tipo I e sua relação com perfil sérico e resposta a atorvastatina em indivíduos brasileiros
- Alteration of the expression of efflux and uptake transporters during hypercholesterolemia. Role in variability of atorvastatin response
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
